An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: Safety, tolerability, and effects on glucose, insulin, and glucagon levels - Shenouda, M; Maldonado, M; Wang, Y (Am J Ther, 2012)
Jun 16. [Epub ahead of print]